Navigation Links
Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
Date:5/9/2008

SAN DIEGO, May 9 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA), a company focused on the discovery and development of small- molecule therapeutics for the treatment of HIV, cancer and inflammatory diseases, including gout, today announced that John W. Beck has been appointed Senior Vice President, Finance and Operations and Chief Financial Officer effective May 27, 2008. He will resign from our board of directors shortly thereafter. The Company also reported recent accomplishments and financial results for the first quarter ended March 31, 2008.

Appointment of John W. Beck as Chief Financial Officer

"We are extremely pleased to welcome John Beck as the new Chief Financial Officer of Ardea," said Barry D. Quart, PharmD, Ardea Biosciences' President and CEO. "John has served as a member of our board of directors since June 2007. He is a proven leader with more than 20 years of financial management experience. We believe that he will play an important role in our ongoing success."

Mr. Beck joins Ardea Biosciences from Metabasis Therapeutics, Inc., which he co-founded in 1999 and where he served most recently as Senior Vice President of Finance, Chief Financial Officer and Treasurer. Prior to Metabasis, he served as Director of Finance of Neurocrine Biosciences, Inc., where he played an important role in Neurocrine's 1996 initial public offering. Prior to joining Neurocrine, Mr. Beck held financial management positions at various high technology and financial services companies, including General Dynamics and Ernst and Young LLP. Mr. Beck received a B.A. in accounting from the University of Washington and also holds a Th.B. in theology from a Seattle, Washington-based seminary. Mr. Beck is a licensed (i
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
2. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
10. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
11. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 24, 2014  Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ... from the board of directors and from his positions as ... most recently serving as the company,s president and chief operating ... join the board of directors.  Gary Lyons , a ... chairman. Mr. Gower is expected to remain an employee until ...
(Date:11/24/2014)... 24, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: INO ... President and CEO of Inovio Pharmaceuticals, will be joined by ... the Nasdaq Opening Bell tomorrow, Tuesday November 25, 2014, at ... listing on the Nasdaq Global Select Market.  ... "We are honored to ring the Nasdaq Opening Bell on ...
(Date:11/22/2014)... N.C. , Nov. 22, 2014  Sprout Pharmaceuticals today ... which demonstrate that women treated with flibanserin up to 200 ... The data were presented at the 20 th Annual ... North America in Miami ... in response to the Complete Response Letter and the Formal ...
Breaking Medicine Technology:Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 3Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3
... Va., April 16 Insmed Inc. (Nasdaq:,INSM), a ... it has received approval from the United Kingdom,s ... the Company,s,first clinical study for a follow-on biologic ... form of human G-CSF, is a follow-on,biologic of ...
... Activity in a Variety of Tumor Types, ... ENMD ), a clinical-stage pharmaceutical company developing,therapeutics for ... the presentation of preclinical results for two of ... given by EntreMed,scientists during two poster sessions at ...
Cached Medicine Technology:Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 2Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 4EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting 2EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting 3
(Date:11/26/2014)... (PRWEB) November 26, 2014 Medical suction ... 3.9 out of 5. This score represents steady growth ... three years to 2014 as a result of swelling ... suction machines, which are largely considered nondiscretionary. IBISWorld market ... process, buyers have some degree of flexibility, given the ...
(Date:11/26/2014)... Louisiana Back Institute, leaders of ... minimally invasive spine surgery, announces today the addition ... growing provider network of orthopedic spine surgeons and ... the network’s continuing success providing the most innovative ... who are suffering from orthopedic spine conditions and ...
(Date:11/26/2014)... One of the most important and vital ... her life is choosing the ideal wedding dress and ... to purchase high quality outfits. Today, BellasDress.com has unveiled ... can pick their suitable bridesmaid gowns here at discount ... ladies look scintillating and highlight all their most beautiful ...
(Date:11/26/2014)... News) -- Teens prescribed anti-anxiety or sleep medications ... than other teens, a new study warns. ... abuse assessments on teenagers before prescribing these drugs ... parents don,t realize the abuse potential," said lead ... of Michigan School of Nursing. "These drugs produce ...
(Date:11/26/2014)... HealthDay Reporter TUESDAY, Nov. 25, 2014 (HealthDay ... and Drug Administration will have many restaurant chains posting calorie ... movie theater popcorn and ice cream parlor fare. "Americans ... often consuming less nutritious food and underestimating the calories they ... afternoon news conference. Although listing calorie counts on ...
Breaking Medicine News(10 mins):Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2Health News:Royal Blue Bridesmaid Dresses Now Are Available for Christmas at BellasDress.com 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 3
... to Improve Health: IOM-NAE Health Data Collegiate Challenge" was ... Academy of Engineering to promote interaction among future health ... harnessing new technologies and data to solve vexing health ... students studying engineering, computer science, and health disciplines to ...
... the human genetic code was mapped, expectations among scientists, health ... concerning the promise of genomics research for improving health. ... and bioethics experts cautions against the dangers of inflated expectations ... ways to avoid it while still realizing "the true ...
... Salamon HealthDay Reporter , THURSDAY, Feb. 17 (HealthDay ... weeks early has no discernible impact on babies, a new ... than their full-term peers and those delays may affect their ... term and 1,200 late preterm infants -- those born between ...
... FL (Feb. 17, 2011) -- The 2nd Annual National Women ... 6 at the Hyatt Regency Clearwater Beach, featuring two of ... country as speakers. Keynote speakers will be ... Department of Surgery Surgeon-in-Chief, The Johns Hopkins Hospital, and Nancy ...
... THURSDAY, Feb. 17 (HealthDay News) -- Some 709,000 youngsters aged ... liquor and other alcoholic beverages, a new federal study found. ... drinkers aren,t just getting a friend to buy a six ... liquor cabinet. Some are getting the alcohol directly from a ...
... -- The area of the brain responsible for visual reading ... is a "task machine" instead of a "sensory machine," according ... measured neural activity in eight blind people while they read ... activity in the exact same part of the brain (visual ...
Cached Medicine News:Health News:IOM and NAE launch collegiate challenge aimed at solving health problems 2Health News:Promise of genomics research needs a realistic view 2Health News:Delivery Even a Bit Early May Mean Developmental Delays 2Health News:Delivery Even a Bit Early May Mean Developmental Delays 3Health News:National career symposium offers strategic advice to attract, advance women in surgery 2Health News:Many Kids Who Drink Get Liquor From Home: Report 2Health News:Many Kids Who Drink Get Liquor From Home: Report 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: